EQS-CMS: PharmaSGP Holding SE completes Share Buy-Back Program

Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 2016/1052 Final Reporting for Share Buy-Back Program

PharmaSGP Holding SE completes Share Buy-Back Program

Gräfelfing, Germany, July 10, 2023 PharmaSGP Holding SE (the Company) has announced on January 3, 2023 pursuant to Art. 2 Sec. 1 of the Commission Delegated Regulation (EU) No 2016/1052 to buy back shares for a maximum volume of up to 60,000 shares at a total purchase price (without ancillary costs) of a maximum of up to EUR 1.5 million (the Share Buy-back Program).

The Share Buy-back Program began on January 4, 2023 and ended on July 3, 2023 as originally planned.

In the period from January 4, 2023 (inclusive) until the end of the program on July 3, 2023 (inclusive), a total of 9,787 shares were bought back in the course of the Share Buy-back Program of the Company. This corresponds to a portion of approximately 0.0816 % of the registered share capital of the Company. The purchase price per share amounted to EUR 26.4246 on average. In total, shares were bought back for an overall purchase price of EUR 258,617.49.

Shares were bought back as follows:

Full transaction details are published on the Companys website under https://ir.pharmasgp.com/en/.

The share buy-backs were executed by an independent bank through the stock exchange via the electronic trading platform of the Frankfurt Stock Exchange (XETRA).

Gräfelfing, July 10, 2023

PharmaSGP Holding SE
The Management Board